AAAAAA

   
Results: 1-10 |
Results: 10
Determination of RhD zygosity: Comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach
Authors: Chiu, RWK Murphy, MF Fidler, C Zee, BCY Wainscoat, JS Lo, YMD
Citation: Rwk. Chiu et al., Determination of RhD zygosity: Comparison of a double amplification refractory mutation system approach and a multiplex real-time quantitative PCR approach, CLIN CHEM, 47(4), 2001, pp. 667-672
A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novochildhood acute myeloid leukemia
Authors: Jaju, RJ Fidler, C Haas, OA Strickson, AJ Watkins, F Clark, K Cross, NCP Cheng, JF Aplan, PD Kearney, L Boultwood, J Wainscoat, JS
Citation: Rj. Jaju et al., A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15.5) in de novochildhood acute myeloid leukemia, BLOOD, 98(4), 2001, pp. 1264-1267
Transcription mapping of the 5q-syndrome critical region: Cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs
Authors: Boultwood, J Fidler, C Strickson, AJ Watkins, F Kostrzewa, M Jaju, RJ Muller, U Wainscoat, JS
Citation: J. Boultwood et al., Transcription mapping of the 5q-syndrome critical region: Cloning of two novel genes and sequencing, expression, and mapping of a further six novel cDNAs, GENOMICS, 66(1), 2000, pp. 26-34
Mutation analysis of the SPARC gene in the 5q-syndrome
Authors: Fidler, C Strickson, A Boultwood, J Waincoat, JS
Citation: C. Fidler et al., Mutation analysis of the SPARC gene in the 5q-syndrome, AM J HEMAT, 64(4), 2000, pp. 324-324
Physical mapping of the human ATX1 homologue (HAH1) to the critical regionof the 5q-syndrome within 5q32, and immediately adjacent to the SPARC gene
Authors: Boultwood, J Strickson, AJ Jabs, EW Cheng, JF Fidler, C Wainscoat, JS
Citation: J. Boultwood et al., Physical mapping of the human ATX1 homologue (HAH1) to the critical regionof the 5q-syndrome within 5q32, and immediately adjacent to the SPARC gene, HUM GENET, 106(1), 2000, pp. 127-129
Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase
Authors: Boultwood, J Peniket, A Watkins, F Shepherd, P McGale, P Richards, S Fidler, C Littlewood, TJ Wainscoat, JS
Citation: J. Boultwood et al., Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase, BLOOD, 96(1), 2000, pp. 358-361
The human POP2 gene: Identification, sequencing, and mapping to the critical region of the 5q- syndrome
Authors: Fidler, C Wainscoat, JS Boultwood, J
Citation: C. Fidler et al., The human POP2 gene: Identification, sequencing, and mapping to the critical region of the 5q- syndrome, GENOMICS, 56(1), 1999, pp. 134-136
Telomere length shortening is associated with disease evolution in chronicmyelogenous leukemia
Authors: Boultwood, J Fidler, C Shepherd, P Watkins, F Snowball, J Haynes, S Kusec, R Gaiger, A Littlewood, TJ Peniket, AJ Wainscoat, JS
Citation: J. Boultwood et al., Telomere length shortening is associated with disease evolution in chronicmyelogenous leukemia, AM J HEMAT, 61(1), 1999, pp. 5-9
Gene rearrangements in T-cell lymphoblastic lymphoma
Authors: Pilozzi, E Muller-Hermelink, HK Falini, B De Wolf-Peeters, C Fidler, C Gatter, K Wainscoat, J
Citation: E. Pilozzi et al., Gene rearrangements in T-cell lymphoblastic lymphoma, J PATHOLOGY, 188(3), 1999, pp. 267-270
Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma
Authors: Lo, YMD Hjelm, NM Fidler, C Sargent, IL Murphy, MF Chamberlain, PF Poon, PMK Redman, CWG Wainscoat, JS
Citation: Ymd. Lo et al., Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma, N ENG J MED, 339(24), 1998, pp. 1734-1738
Risultati: 1-10 |